e-learning
resources
Vienna 2009
Monday, 14.09.2009
Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical features of invasive pulmonary aspergillosis in critically ill patients with chronic respiratory diseases: a perspective study
H. Y. He, Q. Y. Zhan (Beijing, China)
Source:
Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Session:
Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Session type:
Thematic Poster Session
Number:
2456
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Y. He, Q. Y. Zhan (Beijing, China). Clinical features of invasive pulmonary aspergillosis in critically ill patients with chronic respiratory diseases: a perspective study. Eur Respir J 2009; 34: Suppl. 53, 2456
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic respiratory diseases: a prospective study
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Clinical features of invasive pulmonary aspergillosis in critical ill patients with chronic respiratory disease
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Clinical features of COPD in patients with chronic pulmonary aspergillosis
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Non invasive spontaneous dual ventilation in critically ill patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Noninvasive ventilation in acute respiratory failure: the recipe for success
Year: 2015
Clinical features of chronic pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
Surveillance for invasive pulmonary aspergillosis in critically ill patients with COVID-19
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Year: 2021
Usefulness of ICU criteria for invasive pulmonary aspergillosis in critically ill patients
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Clinical features of chronic pulmonary aspergillosis in patients with interstitial pneumonia
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
The relevance of chronic obstructive pulmonary disease on mortality in patients with community acquired pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Impact of chronic obstructive pulmonary disease in the outcome of intensive care unit-acquired pneumonia
Source: Annual Congress 2013 –COPD and infections
Year: 2013
Clinical relevance of respiratory pathogens in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Roflumilast in severely ill patients with chronic obstructive pulmonary disease with frequent exacerbations: real-life outcomes
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020
Early diagnosis of invasive pulmonary aspergillus in patients with chronic obstructive pulmonary diseases: a case control study
Source: International Congress 2019 – Airway infection in COPD
Year: 2019
Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy
Source: Eur Respir J, 54 (1) 1802442; 10.1183/13993003.02442-2018
Year: 2019
Which algorithm diagnoses invasive pulmonary aspergillosis best in ICU patients with COPD?
Source: Eur Respir J, 50 (3) 1700532; 10.1183/13993003.00532-2017
Year: 2017
Management of children with interstitial lung diseases: the difficult issue of acute exacerbations
Source: Eur Respir J 2016; 48: 1559-1563
Year: 2016
Clinical characteristics and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Assessment of the characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept